That the stock market is a forward-thinking beast is well known, but this fact has been particularly emphasized by investors during this earnings season. While many companies have delivered excellent reports, a big chunk stumbled when providing – or even deciding to not provide – the anticipated outlook. Investors have shown that what they really what to hear is not only “that was a great quarter,” but that the business has good days ahead. As such, LifeMD (LFMD) gave investors what they wanted to hear. The telehealth provider raised full-year revenue guidance from the $85 million to $95 million range to between $90 and $100 million.
https://www.tipranks.com/news/article/lifemd-stock-is-undervalued-by-over-300-says-analyst
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more LifeMD Charts.
LifeMD (NASDAQ:LFMD)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more LifeMD Charts.